Collaborative usage/research locations
How to use Medicine Library
1．User requirements
(1)
Teaching staff and researchers belonging to universities or public research institutions, who are carrying out collaborative research with researchers from this Institute
2．How to use Medicine Library
(1)
When carrying out collaborative research with researchers from this Institute, and wishing to use research samples at the Medicine Library, please first contact the address below, and then fill out the following necessary items in the “Medicine Library usage application form” and send to the address for submissions as given below.
(2)
Research materials are free of charge in principle, but please cover the transportation expenses for the sending of materials (these expenses must be paid on delivery).
(3)
Documents for submission
Medicine Library usage application form 1 copy
Medicine Library usage application form 1 copy
(4)
Address for submissions and contact
Kakumamachi, Kanazawa City, Ishikawa Prefecture 920-1192
Kanazawa University Cancer Research Institute, Division of Oncology and Molecular Biology
To: Medicine Library
Tel: 076-264-6752
Fax: 076-234-4521
3．Types of Medicine Library available for use
(1)
FDA approved drug library Japan version (ENZO; CB-BML-2841J0100) 
Compound number: 640
Concentration: 2 mg/mL
Library contents: Compounds that are approved by FDA and currently used in medical supplies including Antihistaminergics, Antineoplastics, COX2 inhibitors, etc.
Compound number: 640
Concentration: 2 mg/mL
Library contents: Compounds that are approved by FDA and currently used in medical supplies including Antihistaminergics, Antineoplastics, COX2 inhibitors, etc.
(2)
ICCB known bioactives library Japan version (ENZO; CB-BML-2840J0100)
Compound number: 480
Concentration: 2 mg/ mL (low molecular weight compound), 1 mM or 0.1 mM (bioactive lipids)
Library contents: GPCR ligands, Ion channel modulators, Kinase inhibitor, Lipid biosynthesis inhibitor, Nuclear receptor ligands, etc.
Compound number: 480
Concentration: 2 mg/ mL (low molecular weight compound), 1 mM or 0.1 mM (bioactive lipids)
Library contents: GPCR ligands, Ion channel modulators, Kinase inhibitor, Lipid biosynthesis inhibitor, Nuclear receptor ligands, etc.
(3)
Kinase inhibitor library (ENZO; CB-BML-2832J0100)
Compound number: 80
Concentration: 10 mM
Library contents: Inhibitors of CaM kinase, CDK, EGFR, GSK, IKK, JAK, PDGFR, VEGFR, etc.
Compound number: 80
Concentration: 10 mM
Library contents: Inhibitors of CaM kinase, CDK, EGFR, GSK, IKK, JAK, PDGFR, VEGFR, etc.
(4)
Fatty acid library (ENZO; CB-BML-2803J0100)
Compound number: 68
Concentration: 10 mM
Library contents: Fatty acids with differing degrees of unsaturation (including structural isomers), having a carbon number from 10 to 24
Compound number: 68
Concentration: 10 mM
Library contents: Fatty acids with differing degrees of unsaturation (including structural isomers), having a carbon number from 10 to 24
(5)
Phosphatase inhibitor library (ENZO; CB-BML-2834J0100) solvent DMSO, total capacity at time of purchase 100 µl
Compound number: 33
Concentration: 10 mM
Library contents: Inhibitors of Calcineurin, JSP1, PP1, PTEN, etc.
Compound number: 33
Concentration: 10 mM
Library contents: Inhibitors of Calcineurin, JSP1, PP1, PTEN, etc.
(6)
Autophagy Library (ENZO; CB-BML-28370100)
Compound number: 94
Concentration: 10 mM
Library contents: Compounds inducing or inhibiting autophagy
Compound number: 94
Concentration: 10 mM
Library contents: Compounds inducing or inhibiting autophagy
(7)
Bioactive Lipid Library (ENZO; CB-BML-28000100)
Compound number: 190
Concentration: 1 mM or 0.1 mM
Library contents: Endocnnabinoids, Farnesyl/geranylgeranyl derivatives, hydroxyeicosatetraenoic acids, hepoxilins, Polyunsaturated fatty acids, Leukotriens, etc.
Compound number: 190
Concentration: 1 mM or 0.1 mM
Library contents: Endocnnabinoids, Farnesyl/geranylgeranyl derivatives, hydroxyeicosatetraenoic acids, hepoxilins, Polyunsaturated fatty acids, Leukotriens, etc.
(8)
Epigenetics Library (ENZO; CB-BML-28360100)
Compound number: 43
Concentration: 10 mM
Library contents: Various compounds with activity relating to epigenetics, having differing structures and action mechanisms
Compound number: 43
Concentration: 10 mM
Library contents: Various compounds with activity relating to epigenetics, having differing structures and action mechanisms
(9)
Natural Products Compound Library
Compound number: 502
Concentration: 2 mg/mL
Library contents: Naturally derived compounds such as microbes, plants and ocean products. Some compounds are identified from natural products used for medicinal purposes since ancient times.
Compound number: 502
Concentration: 2 mg/mL
Library contents: Naturally derived compounds such as microbes, plants and ocean products. Some compounds are identified from natural products used for medicinal purposes since ancient times.
(10)
WNT Pathway Library
Compound number: 74
Concentration: 10 mM
Library contents: Various compounds that act in the WNT pathway with differing structures and action mechanisms
Compound number: 74
Concentration: 10 mM
Library contents: Various compounds that act in the WNT pathway with differing structures and action mechanisms
4．Conditions after dispensing
After dispensing 5 µl at a time into a Greiner-produced V-base Microplate (PP type), samples are covered with a Cap Mat (EVA model) and stored at -80 degrees.
5．Provided units
The desired compound library is provided as a set. It is not possible to have a research objective where only one specific medicine is extracted and used.
6．Procedure for provision
After the submitted application form is examined by the Collaborative Usage Facility Management Committee of this Institute, you will be notified by e-mail of the Committee’s decision on the possibility and scale of provision, etc. After research has been completed, please submit a written report (style arbitrary).